Eye implant for diabetes: a bold idea that never got off the ground
NCT ID NCT04198350
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study aimed to transplant insulin-producing cells into the eye's front chamber to treat type 1 diabetes. It planned to enroll 6 people with poor vision in one eye. However, the trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imperial College London, Imperial College Healthcare NHS Trust
London, W2 1PG, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pancreatic islet cells
What this could lead to
If it works, this could offer a new way to control blood sugar in type 1 diabetes without standard liver transplants.
What could go wrong
The study was withdrawn with no participants, so we have no data on safety or effectiveness. Risks include eye complications like infection or vision loss.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.